Table 1.
Sample characteristics
| Stepped care (n = 47) | Care as usual (n = 48) | P value | |
|---|---|---|---|
| Gender, female, n (%) | 16 (34.0) | 14 (29.2) | 0.61 |
| Age in years, mean (s.d.) | 53.3 (8.7) | 55.5 (8.7) | 0.23 |
| BMI, mean (s.d.) | 25.8 (4.0) | 26.4 (3.2) | 0.41 |
| Living with partner, yes, n (%)a | 33 (70.2) | 40 (85.1) | 0.08 |
| Education, n (%)a | 0.06 | ||
| <4-year college degree | 16 (34.0) | 25 (53.2) | |
| ≥4-year college degree | 31 (66.0) | 22 (46.8) | |
| Diagnosis, n (%) | 0.77 | ||
| Non-Hodgkin lymphoma | 19 (40.4) | 17 (35.4) | |
| Hodgkin lymphoma | 5 (10.6) | 4 (8.3) | |
| Multiple myeloma | 23 (48.9) | 27 (56.3) | |
| Type of conditioning, n (%) | 0.36 | ||
| High-dose melphalan (HDM) | 23 (48.9) | 28 (58.3) | |
| BEAM/Z-BEAM | 24 (51.1) | 19 (39.6) | |
| Busulfan/cyclofosfamide | – | 1 (2.1) | |
| Somatic comorbidities, n (%)a | 0.39 | ||
| None | 6 (12.8) | 2 (4.3) | |
| 1 | 19 (40.4) | 18 (38.3) | |
| 2 | 8 (17.0) | 12 (25.5) | |
| 3 or more | 14 (29.8) | 15 (31.9) | |
| Remission status at time of transplantb | 0.85 | ||
| Complete remission | 19 (44.2) | 19 (42.2) | |
| Not in complete remission | 24 (55.8) | 26 (57.8) |
aCare as usual: 1 patient missing data
bStepped care: 4 patients missing data; care as usual: 3 patients missing data